Fresenius Asks 3rd Circ. For Partial Redo Of Generics Opinion
Fresenius urged a Third Circuit panel Monday to reconsider part of its recent opinion reviving antitrust claims against Par Pharmaceuticals over a generic blood pressure medication, saying the circuit court's ruling...To view the full article, register now.
Already a subscriber? Click here to view full article